On Monday, Piper Sandler maintained an Overweight rating on shares of Yeti Holdings Inc. (NYSE:NYSE:YETI), with a steady price target of $55.00. The firm expressed confidence in the company's ...

NEW YORK, October 18, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of ...

Investing.com -- Piper Sandler analysts revised their election forecasts, giving former President Donald Trump a slight edge in the presidential race and increasing the likelihood of a Republican ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC Partners, today announced a strategic alliance.

Fintel reports that on November 8, 2024, Piper Sandler downgraded their outlook for Celanese (LSE:0HUR) from Neutral to Underweight. As of October 22, 2024, the average one-year price target for ...

Fintel reports that on November 8, 2024, Piper Sandler upgraded their outlook for Upstart Holdings (NasdaqGS:UPST) from Neutral to Overweight. As of October 22, 2024, the average one-year price ...

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its price target on the content delivery company after it reported ...

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the ...

Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to Underweight from Neutral with a $98 price target, slashed from $150 ...

NEW YORK, October 18, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of ...

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of $21.00. The company’s shares ...